Melvin John Martin, Group President of Darden Restaurants Inc, reported the sale of 5,091 shares of common stock on April 6, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares were sold for approximately $998,040, at a per-share price of $196.0401 - a level slightly above the stock's trading price of $194.25 at the time noted in the filing.
The Form 4 also discloses that Martin exercised options to acquire 5,091 shares of Darden common stock at an exercise price of $124.24 per share, for an aggregate exercise value of $632,505. Following the completion of the exercise and sale, Martin's direct ownership in Darden Restaurants stands at 17,270.15 shares. That total includes shares obtained through the Darden Restaurants, Inc. Employee Stock Purchase Plan and by participating in the plan's dividend reinvestment feature.
Darden Restaurants is identified in the filing as a company with a market value of $22.3 billion and a dividend yield of 3.05%. The company has sustained dividend payments for 32 consecutive years. The filing also notes that InvestingPro subscribers have access to additional tips and financial metrics for DRI.
Separately, Darden's fiscal third-quarter 2026 results were reported as exceeding expectations. Earnings beat estimates by $0.01 per share, while revenue came in at $3.35 billion, surpassing projections by $12 million. The earnings release and results have prompted several analysts to adjust their views and targets.
Argus raised its price target on Darden to $240 while keeping a Buy rating. Wolfe Research reiterated an Outperform rating, pointing to strength in the LongHorn and Fine Dining segments. Evercore ISI increased its target to $230, citing market share gains and improved menu management at Olive Garden. KeyBanc lifted its price target to $226, referencing solid third-quarter results and positive fourth-quarter guidance. Morgan Stanley maintained an Overweight rating with a $236 price target, highlighting robust same-store sales and optimistic fourth-quarter sales-growth guidance.
These analyst updates followed the company's quarterly beat and collectively reflect a generally positive reaction from coverage firms. The SEC filing provides transaction details for Martin's exercise and sale, and the earnings release supplies the context for recent analyst activity.
While the Form 4 outlines the mechanics and figures related to Martin's transactions - including the exact exercise price, sale price, and resulting ownership stake - it does not provide an explanation for the sale itself. Likewise, the earnings and analyst commentary cited are limited to the results and the analysts' stated ratings and targets as disclosed in company and market communications.